Anavex Life Sciences Corp.

NASDAQ:AVXL

Biotechnology

Healthcare
$0.72 -1.67%

-$0.04 today

Market cap
$66.69M
Beta
1.12
P/E (TTM)
-5.9
EPS (TTM)
-$0.45
52W Low $2.41High $13.99

Volume 1.06M

Average 1.39M

AVXL Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

Anavex Life Sciences Corp.NASDAQ: AVXL

Other Income / Expenses · Q1 FY2026 · quarter ended Dec 2025

Other income / expenses declines year over year

Q1 FY2026 other income / expenses of $1.12M fell 24.4% year over year, ahead of the -45.3% change in trailing-twelve-month other income / expenses. Sequentially, it rose 10.0% from the prior quarter. Over 3 fiscal years it compounded at +14.3% a year.

Context

  • Other income / expenses increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -24.4% holds above the trailing-twelve-month pace of -45.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterDec 2025
$1.12M+10.0% QoQ
Last fiscal yearSep 2025
$5.03M-49.1% YoY
LTMDec 2025
$4.67M-45.3% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-24.4%——
1 year-49.1%——
3-year CAGR+14.3%——
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

USD · from the income statement

Latest · FY2025
5.03M USD
Year-over-year change
-49.1%
4-year CAGR
+3.6%

Other Income / Expenses vs competitors

How AVXL compares with its peers on the latest reported figures

  • Peers report in different currencies, so other income / expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -45.3% is the 5th highest of 10, against a peer median of -61.4%.
  • Over three fiscal years its annual growth of +14.3% compares with a peer median of +90.7%.
AVXL Competitors
Other Income / Expenses for AVXL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ARVNArvinas, Inc.LTM Mar 2026$28.7M USD-42.1%+178.1%32.1%
MBXMBX Biosciences, Inc. Common StockLTM Sep 2026$15.24M USD+46.9%——
ABSIAbsci CorporationLTM Mar 2026$10.19M USD+78.9%+90.7%555.0%
MLTXMoonLake ImmunotherapeuticsLTM Mar 2026$8.98M USD-61.4%+194.6%—
CTMXCytomX Therapeutics, Inc.LTM Mar 2026$5.75M USD-2.2%+37.4%16.2%
AVXLAnavex Life Sciences Corp.LTM Dec 2025$4.67M USD-45.3%+14.3%—
MGTXMeiraGTx Holdings plcLTM Mar 2026-$15.34M USD-85.0%—19.2%
RGNXREGENXBIO Inc.LTM Mar 2026-$33.33M USD-9907.5%—37.9%
VALNValneva SELTM Mar 2026-€38.24M EUR-120.8%—24.5%
ERASErasca, Inc.LTM Sep 2026-$130.29M USD-898.0%+13.9%—
Peer median (excluding AVXL) —-61.4%+90.7%28.3%

Competitors are the stored peer set for AVXL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Sep 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development32.98M37.92M43.72M41.84M37.59M
Selling, General & Admin9.02M13.07M12.05M11.04M13.82M
Operating Expenses42M50.99M55.76M52.88M51.41M
Depreciation & Amortization00000
EBITDA(37.64M)(47.62M)(46.54M)(43M)(46.38M)
EBITDA Margin—————
Operating Income(42M)(50.99M)(55.76M)(52.88M)(51.41M)
Operating Margin—————
Interest Income26K947K6.52M7.32M4.68M
Interest Expense00964K00
Other Income / Expenses4.36M3.37M8.26M9.88M5.03M
Income Before Tax(37.64M)(47.62M)(47.51M)(43M)(46.38M)
Pre-Tax Margin—————
Income Tax Expense268K358K000
Net Income(37.91M)(47.98M)(47.51M)(43M)(46.38M)
Net Margin—————
EPS (Basic)(0.54)(0.62)(0.60)(0.52)(0.54)
EPS (Diluted)(0.54)(0.62)(0.60)(0.52)(0.54)
Weighted Avg Shares69.8M76.91M79.79M83.47M85.29M
Weighted Avg Shares (Diluted)69.8M76.91M79.79M83.47M85.29M

Anavex Life Sciences Corp.

NASDAQ:AVXL

Intrinsic Alpha fair value

Locked

Current Price

$0.72

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.